Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Muscular and Cerebral Oxygenation Changes After Moderate-Intensity Exercise in Sedentary Older Adults With Type 2 Diabetes
Verified date | September 2021 |
Source | State University of New York at Buffalo |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of the study is to determine the physiological evidence of how muscular and cerebral oxygenation changes link to fatigue, physical, and cognitive performance after moderate-intensity exercise in sedentary older adults with type 2 diabetes.
Status | Completed |
Enrollment | 81 |
Est. completion date | June 27, 2021 |
Est. primary completion date | June 27, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 60 Years and older |
Eligibility | Inclusion Criteria: - For the intervention group, the inclusion criteria are - sedentary older adults 60 years or older who are living in their homes in the community - diagnosed type 2 diabetes - ambulatory with or without mobility devices such as a cane and/or walker - Be able to follow simple exercise instructions without assistance. - For the comparison group, the inclusion criteria are - individuals aged 60 years or older who are living in their homes, in the community; - ambulatory with or without devices; - able to follow simple exercise instructions without assistance - able to walk six minutes as quickly as possible without any adverse symptoms including extreme pain on feet or joints, dizziness, vertigo, or nausea. Exclusion Criteria: - For the intervention group, the exclusion criteria are - foot deformities, cuts, blisters, or amputation, Achilles tendonitis, joint replacements within the past three months, Parkinson's disease, retinopathy such as severe glaucoma, current or uncontrolled vestibular disorders - current smoking or smoking within the last 12 months - current cardiopulmonary diseases, vascular disease, or stroke - dementia indicating the inability to follow exercise instructions independently - those who are currently or plan to receive physical therapy in the following three months - individuals without English proficiency will be excluded - If the individuals with blood glucose level are over 400 mg/dL or HbA1C > 8.0%, and - type 1 diabetes. For the comparison group, the exclusion criteria are - individuals who have prediabetes, diabetes, or current cardiopulmonary diseases and stroke - current smoking or smoking within the last 12 months - individuals with foot deformities, cuts, blisters, or amputation, Achilles tendonitis, joint replacements within the past three months, Parkinson's disease, retinopathy such as severe glaucoma, current or uncontrolled vestibular disorders, and dementia. |
Country | Name | City | State |
---|---|---|---|
United States | University at Buffalo | Buffalo | New York |
Lead Sponsor | Collaborator |
---|---|
State University of New York at Buffalo |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | normalized ?SmO2 rate | a parameter of muscular oxygenation to indicate the match or mismatch between oxygen supply and oxygen demand during the physical stimulus. | measure twice, at baseline and after 2 months | |
Primary | recovery time | a parameter of muscular oxygenation, time taken in seconds after the exercise to back to the beginning oxygenation level. | measure twice, at baseline and after 2 months | |
Primary | Resting SmO2 | a parameter of muscular oxygenation, the average oxygenation level in % while sitting still for 3 minutes before doing physical performance tests. | measure twice, at baseline and after 2 months | |
Primary | Oxyhemoglobin differences | a parameter of cerebral oxygenation, the difference of the oxyhemoglobin in mL per gram before and after the cognitive tests. | measure twice, at baseline and after 2 months | |
Secondary | Fatigue | Fatigue will be assessed by the Numeric Fatigue Scale (NFS) by selecting a number from 0 to 10. 0 is no fatigued at all, 10 is extremely fatigued. | measure twice, at baseline and after 2 months | |
Secondary | Timed Up and Go test score in seconds | An assessment of physical performance. Time in seconds from sitting up from a chair, walking to 3 meters, turning, walking back to sitting down on a chair. | measure twice, at baseline and after 2 months | |
Secondary | Short Physical Performance Battery | An assessment of physical performance. This test contains three sections: balance, walking speed and chair stand. The scores are 0-12. | measure twice, at baseline and after 2 months | |
Secondary | Bilateral Heel Raise test | An assessment of physical performance. This test askes to do heel raise to the maximum height continuously. Time to fatigued in seconds and the frequencies of heel raise are recorded. | measure twice, at baseline and after 2 months | |
Secondary | 6 Minute Walking Test | An assessment of physical performance. The test assesses time in seconds when participants walk as fast as they can in 6 minutes. | measure twice, at baseline and after 2 months | |
Secondary | Mini-cog test | An assessment of cognitive performance. A Short term memory test. | measure twice, at baseline and after 2 months | |
Secondary | Trail Making Test | An assessment of cognitive performance. A executive function test. | measure twice, at baseline and after 2 months | |
Secondary | blood glucose level in mg/dL | Blood glucose level before and after exercise | measure twice, at baseline and after 2 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |